Capstone Therapeutics Corp
OTC:CAPS

Watchlist Manager
Capstone Therapeutics Corp Logo
Capstone Therapeutics Corp
OTC:CAPS
Watchlist
Price: 0.74 USD -2.63% Market Closed
Market Cap: 6.1m USD

Wall Street
Price Targets

CAPS Price Targets Summary
Capstone Therapeutics Corp

Wall Street analysts forecast CAPS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPS is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
719% Upside
Average
Price Target
6.12 USD
727% Upside
Highest
Price Target
6.3 USD
751% Upside
Capstone Therapeutics Corp Competitors:
Price Targets
301207
Hualan Biological Bacterin Inc
2% Upside
LCTX
Lineage Cell Therapeutics Inc
169% Upside
SPRY
ARS Pharmaceuticals Inc
147% Upside
GNS
Genus PLC
15% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
29% Upside
CAPR
Capricor Therapeutics Inc
75% Upside
RLYB
Rallybio Corp
39% Upside

Revenue
Forecast

Revenue Estimate
Capstone Therapeutics Corp

Revenue forecast
is not available for
Capstone Therapeutics Corp

Operating Income
Forecast

Operating Income Estimate
Capstone Therapeutics Corp

Operating Income forecast
is not available for
Capstone Therapeutics Corp

Net Income
Forecast

Net Income Estimate
Capstone Therapeutics Corp

Net Income forecast
is not available for
Capstone Therapeutics Corp
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAPS's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CAPS is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Back to Top